| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 780 | ₹0.8 0% | 19,3750% |
| - | - | 800 | ₹0.75 -16.66% | 68,2000% |
| - | - | 820 | ₹2 0% | 3,8750% |
| 1,5500% | ₹89.05 0% | 830 | ₹2 0% | 3,1000% |
| - | - | 840 | ₹3 0% | 19,3750% |
| 9,3000% | ₹69 0% | 850 | ₹2.65 -15.87% | 72,850-3.09% |
| 00% | ₹60 0% | 860 | ₹5.35 6.99% | 20,9250% |
| - | - | 870 | ₹4.6 -20% | 27,1259.37% |
| 7,7500% | ₹45.45 0.33% | 880 | ₹6.35 -21.11% | 1,40,275-1.63% |
| 3,8750% | ₹32.25 0% | 890 | ₹9.6 0% | 38,7500% |
| 1,78,250-0.43% | ₹34.3 14.71% | 900 | ₹11.5 -19.58% | 2,76,675-1.10% |
| 1,22,450-0.62% | ₹26.5 10.41% | 910 | ₹15.45 -14.64% | 93,775-11.67% |
| 1,90,6501.23% | ₹21 11.11% | 920 | ₹19.75 -13.18% | 1,64,300-0.93% |
| 1,28,650-0.59% | ₹16.45 12.67% | 930 | ₹23.8 -18.21% | 50,375-2.98% |
| 1,76,700-0.43% | ₹12.5 13.63% | 940 | ₹37 0% | 32,5500% |
| 3,00,7000.51% | ₹9.35 8.72% | 950 | ₹43 3.61% | 88,3500% |
| 91,450-1.66% | ₹7.2 9.92% | 960 | ₹53 0% | 12,4000% |
| 38,7508.69% | ₹5.2 14.28% | 970 | ₹56.8 0% | 1,5500% |
| 94,5500% | ₹4 3.89% | 980 | ₹53.85 0% | 6,9750% |
| 15,5000% | ₹2.8 0% | 990 | - | - |
| 1,51,9000% | ₹2.35 6.81% | 1,000 | ₹87.4 0% | 26,3500% |
| 37,2000% | ₹1.35 0% | 1,020 | - | - |
| 11,6250% | ₹0.7 0% | 1,040 | - | - |
| - | - | 1,050 | ₹136.25 0% | 7,7500% |
| 2,3250% | ₹0.7 0% | 1,080 | - | - |
| 6,9750% | ₹0.5 11.11% | 1,100 | ₹177 0% | 4,6500% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
